Logo image of IFX.DE

INFINEON TECHNOLOGIES AG (IFX.DE) Stock Fundamental Analysis

FRA:IFX - Deutsche Boerse Ag - DE0006231004 - Common Stock - Currency: EUR

34.695  +0.65 (+1.89%)

Fundamental Rating

4

Taking everything into account, IFX scores 4 out of 10 in our fundamental rating. IFX was compared to 51 industry peers in the Semiconductors & Semiconductor Equipment industry. IFX has an average financial health and profitability rating. While showing a medium growth rate, IFX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year IFX was profitable.
IFX had a positive operating cash flow in the past year.
IFX had positive earnings in each of the past 5 years.
IFX had a positive operating cash flow in each of the past 5 years.
IFX.DE Yearly Net Income VS EBIT VS OCF VS FCFIFX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

The Return On Assets of IFX (3.13%) is worse than 70.59% of its industry peers.
Looking at the Return On Equity, with a value of 5.11%, IFX is doing worse than 68.63% of the companies in the same industry.
IFX has a worse Return On Invested Capital (5.98%) than 64.71% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IFX is below the industry average of 15.59%.
The 3 year average ROIC (11.24%) for IFX is well above the current ROIC(5.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.13%
ROE 5.11%
ROIC 5.98%
ROA(3y)7.79%
ROA(5y)5.95%
ROE(3y)13.34%
ROE(5y)10.66%
ROIC(3y)11.24%
ROIC(5y)8.52%
IFX.DE Yearly ROA, ROE, ROICIFX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

IFX has a Profit Margin of 6.34%. This is in the lower half of the industry: IFX underperforms 74.51% of its industry peers.
In the last couple of years the Profit Margin of IFX has declined.
Looking at the Operating Margin, with a value of 12.38%, IFX is doing worse than 62.75% of the companies in the same industry.
IFX's Operating Margin has improved in the last couple of years.
IFX has a worse Gross Margin (39.68%) than 68.63% of its industry peers.
In the last couple of years the Gross Margin of IFX has grown nicely.
Industry RankSector Rank
OM 12.38%
PM (TTM) 6.34%
GM 39.68%
OM growth 3Y8.56%
OM growth 5Y3.29%
PM growth 3Y-6.29%
PM growth 5Y-4.73%
GM growth 3Y1.76%
GM growth 5Y1.71%
IFX.DE Yearly Profit, Operating, Gross MarginsIFX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

IFX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
IFX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for IFX has been increased compared to 5 years ago.
The debt/assets ratio for IFX is higher compared to a year ago.
IFX.DE Yearly Shares OutstandingIFX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
IFX.DE Yearly Total Debt VS Total AssetsIFX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 3.56 indicates that IFX is not in any danger for bankruptcy at the moment.
IFX has a worse Altman-Z score (3.56) than 66.67% of its industry peers.
IFX has a debt to FCF ratio of 7.98. This is a slightly negative value and a sign of low solvency as IFX would need 7.98 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.98, IFX is in line with its industry, outperforming 45.10% of the companies in the same industry.
IFX has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.26, IFX is in line with its industry, outperforming 49.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 7.98
Altman-Z 3.56
ROIC/WACC0.61
WACC9.77%
IFX.DE Yearly LT Debt VS Equity VS FCFIFX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.98 indicates that IFX should not have too much problems paying its short term obligations.
IFX has a worse Current ratio (1.98) than 60.78% of its industry peers.
IFX has a Quick Ratio of 1.11. This is a normal value and indicates that IFX is financially healthy and should not expect problems in meeting its short term obligations.
IFX has a Quick ratio of 1.11. This is in the lower half of the industry: IFX underperforms 70.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.11
IFX.DE Yearly Current Assets VS Current LiabilitesIFX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

IFX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.52%.
IFX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.75% yearly.
Looking at the last year, IFX shows a decrease in Revenue. The Revenue has decreased by -8.30% in the last year.
Measured over the past years, IFX shows a quite strong growth in Revenue. The Revenue has been growing by 13.25% on average per year.
EPS 1Y (TTM)-29.52%
EPS 3Y15.94%
EPS 5Y15.75%
EPS Q2Q%-19.05%
Revenue 1Y (TTM)-8.3%
Revenue growth 3Y10.58%
Revenue growth 5Y13.25%
Sales Q2Q%-1.13%

3.2 Future

The Earnings Per Share is expected to grow by 10.26% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.89% on average over the next years.
EPS Next Y-14.23%
EPS Next 2Y8.38%
EPS Next 3Y12.89%
EPS Next 5Y10.26%
Revenue Next Year0.27%
Revenue Next 2Y5.38%
Revenue Next 3Y6.89%
Revenue Next 5Y6.89%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IFX.DE Yearly Revenue VS EstimatesIFX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
IFX.DE Yearly EPS VS EstimatesIFX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.68, which indicates a rather expensive current valuation of IFX.
IFX's Price/Earnings is on the same level as the industry average.
IFX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.35, which is the current average of the S&P500 Index.
IFX is valuated correctly with a Price/Forward Earnings ratio of 15.80.
IFX's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.20. IFX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.68
Fwd PE 15.8
IFX.DE Price Earnings VS Forward Price EarningsIFX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IFX is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IFX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 67.73
EV/EBITDA 12.7
IFX.DE Per share dataIFX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

IFX's earnings are expected to grow with 12.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)1.38
EPS Next 2Y8.38%
EPS Next 3Y12.89%

5

5. Dividend

5.1 Amount

IFX has a Yearly Dividend Yield of 1.01%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.40, IFX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, IFX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.01%

5.2 History

On average, the dividend of IFX grows each year by 6.41%, which is quite nice.
Dividend Growth(5Y)6.41%
Div Incr Years3
Div Non Decr Years3
IFX.DE Yearly Dividends per shareIFX.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

48.98% of the earnings are spent on dividend by IFX. This is a bit on the high side, but may be sustainable.
The dividend of IFX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.98%
EPS Next 2Y8.38%
EPS Next 3Y12.89%
IFX.DE Yearly Income VS Free CF VS DividendIFX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
IFX.DE Dividend Payout.IFX.DE Dividend Payout, showing the Payout Ratio.IFX.DE Dividend Payout.PayoutRetained Earnings

INFINEON TECHNOLOGIES AG

FRA:IFX (5/27/2025, 5:36:15 PM)

34.695

+0.65 (+1.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-05 2025-08-05/amc
Inst Owners53.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap45.31B
Analysts80.65
Price Target41.39 (19.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.01%
Yearly Dividend0.35
Dividend Growth(5Y)6.41%
DP48.98%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.37%
Min EPS beat(2)2.81%
Max EPS beat(2)23.94%
EPS beat(4)4
Avg EPS beat(4)9.72%
Min EPS beat(4)1.58%
Max EPS beat(4)23.94%
EPS beat(8)8
Avg EPS beat(8)9.31%
EPS beat(12)12
Avg EPS beat(12)9.09%
EPS beat(16)14
Avg EPS beat(16)8.5%
Revenue beat(2)1
Avg Revenue beat(2)1.54%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)5.55%
Revenue beat(4)1
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-3.32%
Max Revenue beat(4)5.55%
Revenue beat(8)3
Avg Revenue beat(8)-0.34%
Revenue beat(12)6
Avg Revenue beat(12)0.43%
Revenue beat(16)8
Avg Revenue beat(16)0.38%
PT rev (1m)-3.11%
PT rev (3m)-4.26%
EPS NQ rev (1m)-1.98%
EPS NQ rev (3m)4.23%
EPS NY rev (1m)0%
EPS NY rev (3m)1.46%
Revenue NQ rev (1m)-0.6%
Revenue NQ rev (3m)4.3%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE 21.68
Fwd PE 15.8
P/S 3.09
P/FCF 67.73
P/OCF 13.07
P/B 2.48
P/tB 5.63
EV/EBITDA 12.7
EPS(TTM)1.6
EY4.61%
EPS(NY)2.2
Fwd EY6.33%
FCF(TTM)0.51
FCFY1.48%
OCF(TTM)2.65
OCFY7.65%
SpS11.24
BVpS13.96
TBVpS6.17
PEG (NY)N/A
PEG (5Y)1.38
Profitability
Industry RankSector Rank
ROA 3.13%
ROE 5.11%
ROCE 7.35%
ROIC 5.98%
ROICexc 6.49%
ROICexgc 11.74%
OM 12.38%
PM (TTM) 6.34%
GM 39.68%
FCFM 4.56%
ROA(3y)7.79%
ROA(5y)5.95%
ROE(3y)13.34%
ROE(5y)10.66%
ROIC(3y)11.24%
ROIC(5y)8.52%
ROICexc(3y)13.19%
ROICexc(5y)10.13%
ROICexgc(3y)27.93%
ROICexgc(5y)22.61%
ROCE(3y)13.84%
ROCE(5y)10.48%
ROICexcg growth 3Y-5.66%
ROICexcg growth 5Y1.68%
ROICexc growth 3Y6.77%
ROICexc growth 5Y-4.81%
OM growth 3Y8.56%
OM growth 5Y3.29%
PM growth 3Y-6.29%
PM growth 5Y-4.73%
GM growth 3Y1.76%
GM growth 5Y1.71%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 7.98
Debt/EBITDA 1.28
Cap/Depr 147.52%
Cap/Sales 19.06%
Interest Coverage 250
Cash Conversion 93.35%
Profit Quality 71.86%
Current Ratio 1.98
Quick Ratio 1.11
Altman-Z 3.56
F-Score5
WACC9.77%
ROIC/WACC0.61
Cap/Depr(3y)151.77%
Cap/Depr(5y)128.29%
Cap/Sales(3y)17.6%
Cap/Sales(5y)15.83%
Profit Quality(3y)37.85%
Profit Quality(5y)92.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-29.52%
EPS 3Y15.94%
EPS 5Y15.75%
EPS Q2Q%-19.05%
EPS Next Y-14.23%
EPS Next 2Y8.38%
EPS Next 3Y12.89%
EPS Next 5Y10.26%
Revenue 1Y (TTM)-8.3%
Revenue growth 3Y10.58%
Revenue growth 5Y13.25%
Sales Q2Q%-1.13%
Revenue Next Year0.27%
Revenue Next 2Y5.38%
Revenue Next 3Y6.89%
Revenue Next 5Y6.89%
EBIT growth 1Y-51.42%
EBIT growth 3Y20.04%
EBIT growth 5Y16.98%
EBIT Next Year45.14%
EBIT Next 3Y32.02%
EBIT Next 5Y23.07%
FCF growth 1Y-48.85%
FCF growth 3Y-66.12%
FCF growth 5Y-16.47%
OCF growth 1Y-9.15%
OCF growth 3Y-3.2%
OCF growth 5Y11.67%